Nov 11 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON - US DOD NAVAL MEDICAL RESEARCH CENTER REPORTS POSITIVE IMMUNOLOGICAL RESPONSES TO VACCINE
* IMMURON LTD - NMRC DEMONSTRATED FUNCTIONAL ANTIBODIES IN NEW ORAL THERAPEUTIC TARGETING CAMPYLOBACTER AND ETEC
* IMMURON LTD - TWO HUMAN PHASE II CLINICAL TRIALS TO BE CONDUCTED IN 2021 BY US NMRC